Search

for
Search:

GlossaryNorethisterone

synthetic hormone used in birth control and hormone therapy

Norethisterone, also known as norethindrone, is a synthetic form of the hormone progesterone. It is commonly used in hormonal contraceptives and hormone replacement therapy to regulate menstrual cycles, treat endometriosis, and manage symptoms of menopause.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 103 results

research The Efficacy of an Adjuvant Norethisterone (Jenapharm) Therapy in Endometrial Cancer

January 1987 in “Journal of steroid biochemistry/Journal of Steroid Biochemistry”

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

research Combined Hormonal Contraception and Venous Thromboembolism

46 citations , January 2007 in “The European Journal of Contraception & Reproductive Health Care”

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

research The Effects of Synthetic 19-Norprogestins on Osteoblastic Cell Function Are Mediated by Their Non-Phenolic Reduced Metabolites

13 citations , May 2007 in “Journal of Endocrinology”

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

research Progestogens in Menopausal Hormone Therapy

10 citations , January 2015 in “Przeglad Menopauzalny”

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Use of Combined Oral Contraceptives and Risk of Venous Thromboembolism in Young Women: A Nested Case-Control Analysis Using German Claims Data

research Use of Combined Oral Contraceptives and Risk of Venous Thromboembolism in Young Women: A Nested Case-Control Analysis Using German Claims Data

3 citations , July 2022 in “BJOG: An International Journal of Obstetrics and Gynaecology”

Some birth control pills increase young women's risk of blood clots more than others.

View more "norethisterone" in research →

Community Join

1 / 1 results

community IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia

in Research/Science 13 upvotes 1 year ago

IGFBP‐rP1 shows potential for treating androgenic alopecia by influencing hair cycle transitions. Increasing IGF-1 levels may have similar effects to Minoxidil and 5-AR inhibitors in reducing hair loss.